Mycosafe and ViruSure: Two Austrian biosafety companies expand to Asia

24-Mar-2009 - Singapore

Mycosafe Diagnostics GmbH and ViruSure GmbH announced that they are to establish a second site in Singapore as part of a joint venture.

In the biopharmaceutical and biotechnology industry, contamination with mycoplasmas, viruses and prions can result in losses worth millions if they are detected too late due to a lack of warning signs or inadequate contamination checks. The knock-on effect is that therapeutics are not approved for the market due to inconsistencies in the manufacturing process, diminished quality and possible risks to health.

Mycosafe is now to establish its first branch abroad with the site in Singapore. Founder and Managing Director of Mycosafe Prof. Renate Rosengarten explains: "As mycoplasmas have the potential to cause considerable damage, well-defined mycoplasma biosafety testing procedures are laid down in international regulatory protocols. Based on these standard procedures, more rapid and technologically innovative alternative test methods have recently been developed and are currently being validated for compliance with the regulatory requirements. Mycosafe began specialising in this niche in the market five years ago and is now one of the few providers worldwide that can offer sound scientific and regulatory know-how in this area. Our new site in Singapore will enable us to bring this expertise directly to the expanding Asian bioscience and biopharmaceutical industry".

Dr. Andy Bailey, co-founder and Managing Director of ViruSure, explains: "Mycoplasma biosafety demands special scientific and regulatory expertise and experience. Similarly, the detection and management of virus and prion contamination requires state-of-the-art know-how and experience built up over many years. As one of the few companies specialising in this area, ViruSure offers this know-how and experience as part of its customer-focused services and first-class quality standards".

A commercial office based in Singapore's renowned Biopolis is representing both companies to establish new business relationships in the Asia region.

https://www.bionity.com/en/news/98591/mycosafe-and-virusure-two-austrian-biosafety-companies-expand-to-asia.html